|
1.
|
Landis SH, Murray T, Bolden S and Wingo
PA: Cancer statistics, 1999. CA Cancer J Clin. 49:8–31. 1999.
View Article : Google Scholar
|
|
2.
|
Coqueret O: New roles for p21 and p27
cell-cycle inhibitors: a function for each cell compartment? Trends
Cell Biol. 13:65–70. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Bandoh N, Hayashi T, Takahara M, et al:
Loss of p21 expression is associated with p53 mutations and
increased cell proliferation and p27 expression is associated with
apoptosis in maxillary sinus squamous cell carcinoma. Acta
Otolaryngol. 125:779–785. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Lu Y and Cao W: The role of p21
(wafl/cip1) in human colorectal carcinoma cell apoptosis. Zhonghua
Yi Xue Za Zhi. 81:1330–1332. 2001.(In Chinese).
|
|
5.
|
Bissonnette N and Hunting DJ: p21-induced
cycle arrest in G1 protects cells from apoptosis induced by
UV-irradiation or RNA polymerase II blockage. Oncogene.
16:3461–3469. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Ravitz MJ and Wenner CE: Cyclin-dependent
kinase regulation during G1 phase and cell cycle regulation by
TGF-beta. Adv Cancer Res. 71:165–207. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Suzuki A, Ito T, Kawano H, et al: Survivin
initiates procaspase 3/p21 complex formation as a result of
interaction with Cdk4 to resist Fas-mediated cell death. Oncogene.
19:1346–1353. 2000. View Article : Google Scholar
|
|
8.
|
Temme A, Diestelkoetter-Bachert P, Schmitz
M, et al: Increased p21(ras) activity in human fibroblasts
transduced with survivin enhances cell proliferation. Biochem
Biophys Res Commun. 327:765–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Xie X, Clausen OP and Boysen M: Prognostic
significance of p21WAF1/CIP1 expression in tongue squamous cell
carcinomas. Arch Otolaryngol Head Neck Surg. 128:897–902. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Fischer CA, Jung M, Zlobec I, et al:
Co-overexpression of p21 and Ki-67 in head and neck squamous cell
carcinoma relative to a significantly poor prognosis. Head Neck.
33:267–273. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Nemes JA, Nemes Z and Márton IJ:
p21WAF1/CIP1 expression is a marker of poor prognosis in oral
squamous cell carcinoma. J Oral Pathol Med. 34:274–279. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Zhuang Y, Yin HT, Yin XL, Wang J and Zhang
DP: High p27 expression is associated with a better prognosis in
East Asian non-small cell lung cancer patients. Clin Chim Acta.
412:2228–2231. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Kapranos N, Stathopoulos GP, Manolopoulos
L, et al: p53, p21 and p27 protein expression in head and neck
cancer and their prognostic value. Anticancer Res. 21:521–528.
2001.PubMed/NCBI
|
|
14.
|
O’Sullivan B and Shah J: New TNM staging
criteria for head and neck tumors. Seminars Surg Oncol. 21:30–42.
2003.
|
|
15.
|
Zhang M, Zhang P, Zhang C, et al:
Prognostic significance of Bcl-2 and Bax protein expression in the
patients with oral squamous cell carcinoma. J Oral Pathol Med.
38:307–313. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Harper JW, Adami GR, Wei N, Keyomarsi K
and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent
inhibitor of G1 cyclin-dependent kinases. Cell. 75:805–816. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Gu Y, Turck CW and Morgan DO: Inhibition
of CDK2 activity in vivo by an associated 20K regulatory subunit.
Nature. 366:707–710. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Cheng M, Olivier P, Diehl JA, et al: The
p21(Cip1) and p27(Kip1) CDK ‘inhibitors’ are essential activators
of cyclin D-dependent kinases in murine fibroblasts. EMBO J.
18:1571–1583. 1999.
|
|
19.
|
Zhang H, Hannon GJ and Beach D:
p21-containing cyclin kinases exist in both active and inactive
states. Genes Dev. 8:1750–1758. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Soos TJ, Kiyokawa H, Yan JS, et al:
Formation of p27-CDK complexes during the human mitotic cell cycle.
Cell Growth Differ. 7:135–146. 1996.PubMed/NCBI
|
|
21.
|
Blain SW, Montalvo E and Massagué J:
Differential interaction of the cyclin-dependent kinase (Cdk)
inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J Biol
Chem. 272:25863–25872. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
LaBaer J, Garrett MD, Stevenson LF, et al:
New functional activities for the p21 family of CDK inhibitors.
Genes Dev. 11:847–862. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Zhang Y, Fujita N and Tsuruo T:
Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells
from growth arrest to undergoing apoptosis. Oncogene. 18:1131–1138.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Wang Z, Su ZZ, Fisher PB, Wang S, VanTuyle
G and Grant S: Evidence of a functional role for the
cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the
reciprocal regulation of PKC activator-induced apoptosis and
differentiation in human myelomonocytic leukemia cells. Exp Cell
Res. 244:105–116. 1998. View Article : Google Scholar
|
|
25.
|
Gartel AL and Tyner AL: The role of the
cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer
Ther. 1:639–649. 2002.PubMed/NCBI
|
|
26.
|
Narayanan BA, Geoffroy O, Willingham MC,
Re GG and Nixon DW: p53/p21(WAF1/CIP1) expression and its possible
role in G1 arrest and apoptosis in ellagic acid treated cancer
cells. Cancer Lett. 136:215–221. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Okaichi K, Wang LH, Sasaki J, Saya H, Tada
M and Okumura Y: A point mutation of human p53, which was not
detected as a mutation by a yeast functional assay, led to
apoptosis but not p21Waf1/Cip1/Sdi1 expression in response to
ionizing radiation in a human osteosarcoma cell line, Saos-2. Int J
Radiat Oncol Biol Phys. 45:975–980. 1999. View Article : Google Scholar
|
|
28.
|
Yan Q and Sage EH: Transforming growth
factor-beta1 induces apoptotic cell death in cultured retinal
endothelial cells but not pericytes: association with decreased
expression of p21waf1/cip1. J Cell Biochem. 70:70–83. 1998.
View Article : Google Scholar
|
|
29.
|
Gunia S, Kakies C, Erbersdobler A,
Hakenberg OW, Koch S and May M: Expression of p53, p21 and cyclin
D1 in penile cancer: p53 predicts poor prognosis. J Clin Pathol.
65:232–236. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Taghavi N, Biramijamal F, Sotoudeh M, et
al: Association of p53/p21 expression with cigarette smoking and
prognosis in esophageal squamous cell carcinoma patients. World J
Gastroenterol. 16:4958–4967. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Siu MK, Chan HY, Kong DS, et al:
p21-activated kinase 4 regulates ovarian cancer cell proliferation,
migration, and invasion and contributes to poor prognosis in
patients. Proc Natl Acad Sci USA. 107:18622–18627. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Mineo TC, Ambrogi V, Cufari ME and Pompeo
E: May cyclooxygenase-2 (COX-2), p21 and p27 expression affect
prognosis and therapeutic strategy of patients with malignant
pleural mesothelioma? Eur J Cardiothorac Surg. 38:245–252. 2010.
View Article : Google Scholar
|
|
33.
|
Ogino S, Nosho K, Shima K, et al: p21
expression in colon cancer and modifying effects of patient age and
body mass index on prognosis. Cancer Epidemiol Biomarkers Prev.
18:2513–2521. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Hu TH, Tai MH, Chuah SK, et al: Elevated
p21 expression is associated with poor prognosis of rectal stromal
tumors after resection. J Surg Oncol. 98:117–123. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Hafkamp HC, Mooren JJ, Claessen SM, et al:
P21 Cip1/WAF1 expression is strongly associated with HPV-positive
tonsillar carcinoma and a favorable prognosis. Mod Pathol.
22:686–698. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Pasz-Walczak G, Kordek R and Faflik M: P21
(WAF1) expression in colorectal cancer: correlation with P53 and
cyclin D1 expression, clinicopathological parameters and prognosis.
Pathol Res Pract. 197:683–689. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Fillies T, Woltering M, Brandt B, et al:
Cell cycle regulating proteins p21 and p27 in prognosis of oral
squamous cell carcinomas. Oncol Rep. 17:355–359. 2007.PubMed/NCBI
|
|
38.
|
Adida C, Crotty PL, McGrath J, Berrebi D,
Diebold J and Altieri DC: Developmentally regulated expression of
the novel cancer anti-apoptosis gene survivin in human and mouse
differentiation. Am J Pathol. 152:43–49. 1998.PubMed/NCBI
|
|
39.
|
Ambrosini G, Adida C, Sirugo G and Altieri
DC: Induction of apoptosis and inhibition of cell proliferation by
survivin gene targeting. J Biol Chem. 273:11177–11182. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Ambrosini G, Adida C and Altieri DC: A
novel anti-apoptosis gene, survivin, expressed in cancer and
lymphoma. Nat Med. 3:917–921. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Li F, Ackermann EJ, Bennett CF, et al:
Pleiotropic cell-division defects and apoptosis induced by
interference with survivin function. Nat Cell Biol. 1:461–466.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Kobayashi K, Hatano M, Otaki M, Ogasawara
T and Tokuhisa T: Expression of a murine homologue of the inhibitor
of apoptosis protein is related to cell proliferation. Proc Natl
Acad Sci USA. 96:1457–1462. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Li F, Ambrosini G, Chu EY, et al: Control
of apoptosis and mitotic spindle checkpoint by survivin. Nature.
396:580–584. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Suzuki A and Shiraki K: Tumor cell ‘dead
or alive’: caspase and survivin regulate cell death, cell cycle and
cell survival. Histol Histopathol. 16:583–593. 2001.
|
|
45.
|
Fukuda S, Mantel CR and Pelus LM: Survivin
regulates hematopoietic progenitor cell proliferation through
p21WAF1/Cip1-dependent and -independent pathways. Blood.
103:120–127. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Tanaka C, Uzawa K, Shibahara T, Yokoe H,
Noma H and Tanzawa H: Expression of an inhibitor of apoptosis,
survivin, in oral carcinogenesis. J Dent Res. 82:607–611. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Li C, Li Z, Zhu M, et al:
Clinicopathological and prognostic significance of survivin
over-expression in patients with esophageal squamous cell
carcinoma: a meta-analysis. PloS One. 7:e447642012. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Ekeblad S, Lejonklou MH, Stálberg P and
Skogseid B: Prognostic relevance of survivin in pancreatic
endocrine tumors. World J Surg. 36:1411–1418. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Chang BD, Watanabe K, Broude EV, et al:
Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression:
implications for carcinogenesis, senescence, and age-related
diseases. Proc Natl Acad Sci USA. 97:4291–4296. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Schmidt M and Fan Z: Protection against
chemotherapy-induced cytotoxicity by cyclin-dependent kinase
inhibitors (CKI) in CKI-responsive cells compared with
CKI-unresponsive cells. Oncogene. 20:6164–6171. 2001. View Article : Google Scholar
|
